Effect of Anti-inflammatory Diet on Inflammatory, Oxidative and Nutritional Markers in Hemodialysis Patients

January 7, 2014 updated by: Maryam Ekramzadeh, PhD
The purpose of this study is to evaluate the effect of especial diet therapy "Anti-inflammatory Diet" on inflammatory, oxidative stress, and nutritional markers in the context of protein-energy wasting syndrome(PEW) in hemodialysis patients.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fars
      • Shiraz, Fars, Iran, Islamic Republic of
        • Shiraz University of Medical Sciences, Department of Nutrition

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients who are on hemodialysis(HD) at least two times a week for 3months or more without any internment illness or admission

Exclusion Criteria:

  • Hospitalization because of sepsis or surgery 3 months prior to intervention
  • Cirrhosis
  • Hepatitis virus infection
  • Human Immunodeficiency virus infection
  • Acquired Immunodeficiency Syndrome
  • Active malignancy
  • Active infection
  • Absence of communication
  • Mental Impairment
  • Terminal illness
  • Tube feedings
  • Total parenteral nutrition
  • Pregnancy
  • Not previously seen by a dietitian within 3 months prior to enrollment in the study
  • Not expected to be transplanted within 6 months after the enrollment in the study
  • Absence of malnutrition from a cause other than end stage renal disease(ESRD)
  • Psychiatric conditions, preventing adherence to intervention
  • Consuming immunosuppressive drugs or taking antioxidant supplements including Vitamin E, Vitamin C, N-acetyl- cysteine (NAC), Pentoxifylline, Lipoic acid,Fish-oil extracts (omega-3 fatty acids), Soy extracts(isoflavones), Green-tea preparations, Pomegranate extracts, Grape extracts within 2 months prior to enrollment in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Diet therapy
The patients in this arm were educated to follow a especial type of diet (anti-inflammatory diet)in addition to nutrition counseling for 10 weeks.
The patients in this arm were educated to follow a especial type of diet (anti-inflammatory diet)in addition to nutrition counseling for 10 weeks.
Other: Control Group
The patients in this arm received nutrition counseling and education in general based on their needs as a control group for 10 weeks.
The patients in this arm received nutrition counseling and education in general based on their needs as a control group for 10 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in serum Albumin
Time Frame: 10 weeks
10 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in Subjective Global Assessment (SGA) score
Time Frame: 10 weeks
10 weeks
Change in Malnutrition-inflammation score(MIS)
Time Frame: 10 weeks
10 weeks
Change in serum C-Reactive Protein(CRP)
Time Frame: 10 weeks
10 weeks
Change in serum malondialdehyde(MDA)
Time Frame: 10 weeks
10 weeks
Change in serum Interleukin-6(IL-6)
Time Frame: 10 weeks
10 weeks
Change in serum total antioxidant capacity(TAC)
Time Frame: 10 weeks
10 weeks
Change in serum ferritin
Time Frame: 10 weeks
10 weeks
Change in serum total iron binding capacity(TIBC)
Time Frame: 10 weeks
10 weeks
Change in serum urea nitrogen
Time Frame: 10 weeks
10 weeks
Change in serum creatinine
Time Frame: 10 weeks
10 weeks
Change in serum phosphorus
Time Frame: 10 weeks
10 weeks
Change in body fat mass index(BFMI)
Time Frame: 10 weeks
10 weeks
Change in fat free mass index(FFMI)
Time Frame: 10 weeks
10 weeks
Change in body cell mass(BCM)
Time Frame: 10 weeks
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Zohreh Mazloom, PhD, Shiraz University of Medical Sciences, Faculty of Nutrition
  • Study Chair: Mohammadmahdi Sagheb, MD, Shiraz University of Medical Sciences, Nephrology Urology Research Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

April 1, 2013

Study Completion (Actual)

August 1, 2013

Study Registration Dates

First Submitted

June 6, 2013

First Submitted That Met QC Criteria

June 7, 2013

First Posted (Estimate)

June 10, 2013

Study Record Updates

Last Update Posted (Estimate)

January 8, 2014

Last Update Submitted That Met QC Criteria

January 7, 2014

Last Verified

January 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

Clinical Trials on Diet Therapy

Subscribe